Illustration comparing FDA-approved and compounded GLP-1 medications.

WEIGHT MANAGEMENT GLP-1 EDUCATION

FDA-Approved vs. Compounded GLP-1 Medications

Understanding the regulatory pathways, what FDA approval means, and why the distinction matters.

At a Glance

FDA-approved and compounded medications follow different pathways. Understanding the distinction can help you ask better questions about your care.

Key Takeaways

  • FDA-approved and compounded medications do not follow the same regulatory pathway.
  • Compounded drugs are not FDA-approved and are not the same as FDA-approved generic drugs.
  • Compounding can serve an important individual medical need when appropriate.
  • Clinical-trial results for an approved product should not be presented as proof of identical results from a compounded preparation.
  • For compounded prescriptions, formulation, concentration, instructions and measurement details matter.

UNDERSTANDING THE DIFFERENCE

Why the Distinction Matters

GLP-1 medications are discussed widely in weight management, but not every product described with a familiar medication name has gone through the same regulatory process. FDA-approved drugs are reviewed before marketing for safety, effectiveness and quality for their approved uses. Compounded drugs are not FDA-approved and do not undergo that same premarket review. Compounding can serve an important medical need for an individual patient in circumstances allowed by law. The key is not to treat “FDA-approved” and “compounded” as interchangeable descriptions.

WHAT APPROVAL MEANS

What FDA Approval Means

For an FDA-approved medication, FDA reviews evidence supporting the product’s safety, effectiveness and quality before it is marketed for the approved indication. Approved brand-name and generic drugs also operate within FDA requirements that do not apply in the same way to compounded preparations. A compounded medication is not an FDA-approved generic drug. FDA specifically distinguishes compounded drugs from approved generics.

WHEN COMPOUNDING FITS

When Compounding May Be Considered

FDA notes that compounding may be appropriate when an FDA-approved medication cannot meet an individual patient’s medical need — for example, when a patient requires a different dosage form or cannot use a particular ingredient. Federal law also places conditions on when pharmacies and outsourcing facilities may compound drug products. Because rules and availability can change, questions about whether a compounded medication is appropriate should be addressed with the prescribing clinician and dispensing pharmacy.

EVIDENCE HAS LIMITS

Evidence Does Not Automatically Transfer

Clinical trials are conducted using defined products, formulations, doses and study populations. Results from a trial of an FDA-approved semaglutide or tirzepatide product describe what happened with the product and regimen that were actually studied. Those results should not be used to imply that an arbitrary compounded preparation has been shown to produce identical outcomes. This distinction is especially important when reviewing advertising, before-and-after claims or numerical weight-loss comparisons.

PERSONALIZED PRESCRIBING

The Details Matter

With compounded medications, concentration, formulation, directions and measuring devices can vary. Follow the directions supplied for your specific prescription rather than borrowing instructions from another person, another product or an online dosing chart. If the label, measuring device or instructions are unclear, contact the prescribing or dispensing care team before using the medication.

01 Prescription

Confirm what your healthcare provider prescribed.

02 Formulation

Know the medication and concentration that were dispensed.

03 Instructions

Use the directions written for your specific prescription.

04 Measurement

Use the correct amount and measuring device.

05 Monitoring

Know what to watch for and when to contact your care team.

Prepare for Your Visit

Questions to Ask Your Provider

  1. Is an FDA-approved medication appropriate for me, and if not, why is a compounded medication being considered?
  2. Who compounds and dispenses this prescription?
  3. What concentration and formulation am I receiving?
  4. What measuring device should I use, and can you show me how to read it?
  5. What changes or symptoms should prompt me to contact the care team?

Helpful Answers

Frequently Asked Questions

Are compounded GLP-1 medications FDA-approved?

No. FDA states that compounded drugs are not FDA-approved and are not reviewed before marketing for safety, effectiveness or quality in the same way as approved drugs.

Is a compounded drug the same as a generic drug?

No. FDA-approved generic drugs must meet FDA requirements; compounded drugs are not FDA-approved generics.

Why might a clinician consider a compounded medication?

Compounding may meet an individual medical need when an FDA-approved product cannot appropriately meet that need. The reason should be specific to the patient and prescription.

Can I use dosing instructions I found online?

Use only the directions provided for your own prescription. Concentrations and measuring devices can differ.

Do clinical-trial results for branded GLP-1 medications prove the same results for compounded products?

No. Trial results apply to the specific products, regimens and populations studied.

Next Step

Know what you are receiving — and why.

Understanding the regulatory pathway, prescription details and source of a medication can help you have a more informed conversation with your healthcare provider.

Schedule a Free Consultation

References

Sources

  1. Compounding and the FDA: Questions and Answers (updated 2026). — FDA View source
  2. Consumer and Health Care Professional Information — FDA View source
  3. Understanding the Risks of Compounded Drugs. — FDA View source
  4. Communications on misleading promotion of compounded GLP-1 products — FDA View source